Arkadir David, Eichel Roni, Cohen Jose E, Itshayek Eyal, Gomori John M, Ben-Hur Tamir, Rosenthal Guy, Leker Ronen R
Department of Neurology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.
Neurol Res. 2010 Dec;32(10):1077-82. doi: 10.1179/016164110X12700393823372. Epub 2010 May 18.
Decompressive hemicraniectomy reduces morbidity and mortality in patients with large hemispheric stroke. However, its role in patients that underwent failed endovascular reperfusion remains unknown.
Patients with acute stroke secondary to internal carotid artery occlusion who underwent endovascular multimodal reperfusion therapy were evaluated. Patients with failed revascularization who were referred for decompressive hemicraniectomy were compared with patients with failed reperfusion who did not undergo decompressive hemicraniectomy. Functional outcome was assessed with the modified Rankin Score (mRS) and neurological disability with the NIH Stroke Scale Score (NIHSS) at 90 days from stroke onset.
Six decompressive hemicraniectomy-treated patients were included (four females, mean age: 36.7 years, mean NIHSS: 24.5). None of the decompressive hemicraniectomy-treated patients died compared to six of seven patients with failed multi-modal reperfusion therapy that did not undergo decompressive hemicraniectomy. All decompressive hemicraniectomy-treated patients were discharged to a rehabilitation facility whereas the only surviving non-decompressive hemicraniectomy-treated patient was discharged to a nursing facility. Five of the six decompressive hemicraniectomy-treated (84%) and none of the non-decompressive hemicraniectomy-treated patients had an mRS ≤ 3 at 90 days post-stroke.
Decompressive hemicraniectomy can significantly improve functional outcome in patients with large carotid artery strokes that failed to recanalize following multi-modal reperfusion therapy. These results imply that decompressive hemicraniectomy should be planned in patients who undergo multi-modal reperfusion therapy for large carotid artery stroke.
去骨瓣减压术可降低大面积半球性卒中患者的发病率和死亡率。然而,其在血管内再灌注治疗失败的患者中的作用尚不清楚。
对因颈内动脉闭塞继发急性卒中并接受血管内多模式再灌注治疗的患者进行评估。将因血管再通失败而接受去骨瓣减压术的患者与未接受去骨瓣减压术的再灌注失败患者进行比较。在卒中发作90天时,用改良Rankin量表(mRS)评估功能结局,用美国国立卫生研究院卒中量表评分(NIHSS)评估神经功能缺损。
纳入6例接受去骨瓣减压术治疗的患者(4例女性,平均年龄:36.7岁,平均NIHSS:24.5)。与7例未接受去骨瓣减压术的多模式再灌注治疗失败的患者中的6例相比,接受去骨瓣减压术治疗的患者均未死亡。所有接受去骨瓣减压术治疗的患者均出院至康复机构,而唯一存活的未接受去骨瓣减压术治疗的患者出院至护理机构。6例接受去骨瓣减压术治疗的患者中有5例(84%)在卒中后90天时mRS≤3,而未接受去骨瓣减压术治疗的患者均无此情况。
去骨瓣减压术可显著改善多模式再灌注治疗后未能再通的大面积颈动脉卒中患者的功能结局。这些结果表明,对于接受多模式再灌注治疗的大面积颈动脉卒中患者,应考虑行去骨瓣减压术。